journal article·2017-04-26Open access

PEGylated Anionic Magnetofluorescent Nanoassemblies: Impact of Their Interface Structure on Magnetic Resonance Imaging Contrast and Cellular Uptake

Camille Linot, Julien Poly, Joanna Boucard, Daniel Pouliquen, Steven Nedellec, Philippe Hulin, Nadège Marec, Paolo Arosio, Alessandro Lascialfari, Andrea Guerrini, Claudio Sangregorio, Marc Lecouvey, Lénaïc Lartigue, Christophe Blanquart, Eléna Ishow

Abstract

Controlling the interactions of functional nanostructures with water and biological media represents high challenges in the field of bioimaging applications. Large contrast at low doses, high colloidal stability in physiological conditions, the absence of cell cytotoxicity, and efficient cell internalization represent strong additional needs. To achieve such requirements, we report on high-payload magnetofluorescent architectures made of a shell of superparamagnetic iron oxide nanoparticles tightly anchored around fluorescent organic nanoparticles. Their external coating is simply modulated using anionic polyelectrolytes in a final step to provide efficient magnetic resonance imaging (MRI) and fluorescence imaging of live cells. Various structures of PEGylated polyelectrolytes have been synthesized and investigated, differing from their iron oxide complexing units (carboxylic vs phosphonic acid), their structure (block- or comblike), their hydrophobicity, and their fabrication process [conventional or reversible addition–fragmentation chain transfer (RAFT)-controlled radical polymerization] while keeping the central magnetofluorescent platforms the same. Combined photophysical, magnetic, NMRD, and structural investigations proved the superiority of RAFT polymer coatings containing carboxylate units and a hydrophobic tail to impart the magnetic nanoassemblies (NAs) with enhanced-MRI negative contrast, characterized by a high r 2 / r 1 ratio and a transverse relaxation r 2 equal to 21 and 125 s –1 mmol –1 L, respectively, at 60 MHz clinical frequency (∼1.5 T). Thanks to their dual modality, cell internalization of the NAs in mesothelioma cancer cells could be evidenced by both confocal fluorescence microscopy and magnetophoresis. A 72 h follow-up showed efficient uptake after 24 h with no notable cell mortality. These studies again pointed out the distinct behavior of RAFT polyelectrolyte-coated bimodal NAs that internalize at a slower rate with no adverse cytotoxicity. Extension to multicellular tumor cell spheroids that mimic solid tumors revealed the successful internalization of the NAs in the periphery cells, which provides efficient deep-imaging labels thanks to their induced T 2 * contrast, large emission Stokes shift, and bright dotlike signal, popping out of the strong spheroid autofluorescence.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Lanthanide and Transition Metal Complexes · Luminescence and Fluorescent Materials · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

IRS UN, INSERM-UMR 1232, CRCINA, 8 quai Monconsu, 44007 Nantes, France

IS2M, UMR, CNRS 7361, Université de Haute-Alsace, 15 rue Jean Starcky, 68057 Mulhouse, France

CEISAM, UMR, CNRS 6230, Université de Nantes, 2 rue de la Houssinière, 44322 Nantes, France

INSERM, UMS 016, UMS, CNRS 3556, Université de Nantes, 8 quai Moncousu, 44007 Nantes, France

Plateforme CytoCell, INSERM, UMR 1232, Université de Nantes, 44007 Nantes, France

Department of Physics, Università di Pavia, via Bassi, 27100 Pavia, Italy

Department of Physics, Università degli Studi di Milano and INSTM, via Celoria 16, 20133 Milano, Italy

ICCOM-CNR via Madonna del Piano 10, 50019 Sesto Fiorentino, Fiorentino, Italy

CSPBAT-UMR CNRS 7244, Université de Villetaneuse−Paris 13, 74 rue Marcel Cachin, 93017 Bobigny, France

Funding

Ligue Contre le Cancer · Centre National de la Recherche Scientifique · France-Italy partnership

References (65)

Show source-provided references
1. 10.1038/ncomms1013910.1038/ncomms10139 ↗
2. 10.1038/nmeth.340010.1038/nmeth.3400 ↗
3. 10.1002/anie.20150301710.1002/anie.201503017 ↗
4. 10.1038/ncomms609310.1038/ncomms6093 ↗
5. 10.1021/cr300068p10.1021/cr300068p ↗
6. 10.1021/acsnano.6b0287610.1021/acsnano.6b02876 ↗
7. 10.1021/nn305719y10.1021/nn305719y ↗
8. 10.1016/j.biomaterials.2004.10.01210.1016/j.biomaterials.2004.10.012 ↗
9. 10.1016/j.biomaterials.2009.11.01010.1016/j.biomaterials.2009.11.010 ↗
10. 10.1021/cr068445e10.1021/cr068445e ↗
11. 10.1002/adhm.20120007810.1002/adhm.201200078 ↗
12. 10.1021/nn200227210.1021/nn2002272 ↗
13. 10.1021/nn405012h10.1021/nn405012h ↗
14. 10.1021/la302471610.1021/la3024716 ↗
15. 10.1021/cm903155710.1021/cm9031557 ↗
16. 10.1021/nn506949t10.1021/nn506949t ↗
17. 10.1039/c3tc30508b10.1039/c3tc30508b ↗
18. 10.1016/j.jcis.2016.06.06410.1016/j.jcis.2016.06.064 ↗
19. 10.1002/adma.20080084610.1002/adma.200800846 ↗
20. 10.1021/la900833v10.1021/la900833v ↗
21. 10.3390/polym304197210.3390/polym3041972 ↗
22. 10.1039/C4TB01199F10.1039/C4TB01199F ↗
23. 10.1021/bm500832q10.1021/bm500832q ↗
24. 10.1039/C6PY01558A10.1039/C6PY01558A ↗
25. 10.1002/smll.20090115810.1002/smll.200901158 ↗
26. 10.1021/am503909q10.1021/am503909q ↗
27. 10.1021/acsnano.6b0005310.1021/acsnano.6b00053 ↗
28. 10.1021/nn501203k10.1021/nn501203k ↗
29. 10.1021/ja900062u10.1021/ja900062u ↗
30. 10.1039/C5CS00499C10.1039/C5CS00499C ↗
31. 10.1016/j.polymer.2004.02.01810.1016/j.polymer.2004.02.018 ↗
32. 10.1039/c3nr02657d10.1039/c3nr02657d ↗
33. 10.1002/chem.20130264710.1002/chem.201302647 ↗
34. 10.1016/j.jcis.2009.01.03010.1016/j.jcis.2009.01.030 ↗
35. 10.1021/ar030248410.1021/ar0302484 ↗
36. 10.1021/cr900140310.1021/cr9001403 ↗
37. 10.1021/jp111355c10.1021/jp111355c ↗
38. 10.1021/bm901129x10.1021/bm901129x ↗
39. Sumerlin B. S. · 2007 · 110310.1002/9783527631421.ch26 ↗
40. 10.1002/chem.20120300310.1002/chem.201203003 ↗
41. Ishow, E.; Faucon, A.Magnetic and Fluorescent Reverse Nanoassemblies. U.S. 14/218,368, PCT/EP2015/055711, March 2015.
42. 10.1021/acsnano.6b0255910.1021/acsnano.6b02559 ↗
43. 10.1039/B9PY00340A10.1039/B9PY00340A ↗
44. 10.1039/c3cp51369f10.1039/c3cp51369f ↗
45. 10.1002/adhm.20150056210.1002/adhm.201500562 ↗
46. 10.1039/c1cp20877b10.1039/c1cp20877b ↗
47. 10.1021/ma070444g10.1021/ma070444g ↗
48. 10.1021/acsami.6b0137710.1021/acsami.6b01377 ↗
49. 10.1021/nn204591r10.1021/nn204591r ↗
50. 10.1063/1.47843510.1063/1.478435 ↗
51. 10.1039/C6TB00832A10.1039/C6TB00832A ↗
52. 10.1039/C0JM01061H10.1039/C0JM01061H ↗
53. 10.1002/wnan.3610.1002/wnan.36 ↗
54. 10.1002/adhm.20120007810.1002/adhm.201200078 ↗
55. 10.1021/nn900597310.1021/nn9005973 ↗
56. 10.1021/nn304477s10.1021/nn304477s ↗
57. 10.1016/j.ijpharm.2012.01.06010.1016/j.ijpharm.2012.01.060 ↗
58. 10.1021/nn700256c10.1021/nn700256c ↗
59. 10.1038/jcbfm.2009.19210.1038/jcbfm.2009.192 ↗
60. 10.1016/S0006-8993(00)02619-610.1016/S0006-8993(00)02619-6 ↗
61. 10.1002/jmri.188004050610.1002/jmri.1880040506 ↗
62. 10.1016/j.neo.2014.12.00410.1016/j.neo.2014.12.004 ↗
63. 10.1016/j.tibtech.2012.12.00310.1016/j.tibtech.2012.12.003 ↗
64. 10.1088/0957-4484/21/39/39510310.1088/0957-4484/21/39/395103 ↗
65. 10.1021/jp953110e10.1021/jp953110e ↗